Neurocrine biosciences to participate at investor conferences in june

Jefferies global healthcare conference on june 5 in new york goldman sachs 45th annual global healthcare conference on june 13 in miami san diego, may 29, 2024 /prnewswire/ -- neurocrine biosciences, inc. (nasdaq: nbix) will participate at two upcoming investor conferences in june. kevin gorman, chief executive officer, kyle gano, chief business development and strategy officer, and matt abernethy, chief financial officer will present at the jefferies global healthcare conference at 2:30 p.m.
NBIX Ratings Summary
NBIX Quant Ranking